BioXcel Therapeutics

BioXcel Therapeutics is a biopharmaceutical company that develops innovative medicines using artificial intelligence. The company focuses on neuroscience and immuno-oncology, employing a drug re-innovation strategy that repurposes existing approved drugs with advanced machine learning techniques. Its lead product, IGALMI, is designed for treating agitation in patients with schizophrenia or bipolar disorders. BioXcel is also advancing treatments for conditions such as Alzheimer’s disease and various cancers, aiming to address significant unmet medical needs in these areas.

OrphAI Therapeutics

OrphAI Therapeutics is a clinical-stage biopharmaceutical company developing novel treatments for rare diseases and cancer using AI-driven drug discovery. The company targets amyotrophic lateral sclerosis (ALS) and has received orphan drug designation in both the US and EU.

Standigm

Standigm is a biopharmaceutical company that uses artificial intelligence (AI) to streamline and accelerate the process of developing new medications. The company employs advanced AI platforms to identify novel drug targets, design compounds, and optimize lead molecules. Standigm’s technology covers various stages of drug discovery, from target identification to lead generation, with a focus on reducing costs and time compared to traditional methods.

Tissue Dynamics

Tissue Dynamics is a biotechnology company focused on developing innovative therapeutics for cardiovascular and metabolic diseases. By exploring the underlying mechanisms of human metabolism, it creates first-in-class treatments aimed at countering age-related declines in metabolic function.

Iktos

Iktos specializes in transforming drug discovery through advanced AI and robotics. Their platform integrates generative AI for molecular design, retrosynthesis planning, and automated synthesis, significantly speeding up the process of developing new treatments.

Cerella

Cerella is a software platform that utilizes artificial intelligence for drug discovery. The company specializes in creating predictive models, including QSAR and imputation methods, to assist pharmaceutical researchers in analyzing and optimizing chemical compounds.

Valence Labs

Valence Labs is a research-focused entity under Recursion Pharmaceuticals, specializing in the integration of artificial intelligence with drug discovery. The lab develops advanced machine learning models to enhance predictive capabilities in pharmaceutical research.

Xeureka

Xeureka specializes in enhancing drug discovery processes through advanced computational technologies, including artificial intelligence and simulations. The company focuses on improving the efficiency and success rates of research aimed at developing effective medicines for patients.

21 Companies Harnessing Artificial Intelligence to Accelerate Drug Discovery

Discover how these 21 innovative companies are leveraging the power of Artificial Intelligence to revolutionize the drug discovery process. Explore cutting-edge AI-driven solutions that are shaping the future of pharmaceutical research and driving breakthroughs in healthcare.

XtalPi

XtalPi is a research and development company focused on integrating artificial intelligence, quantum physics, cloud computing, and robotics to accelerate drug discovery and materials science innovation. The company also develops automation systems for chemical synthesis and crystallization processes.